Jan-Michael Peters
Born (1962-08-16) 16 August 1962
Schleswig-Holstein, Germany
CitizenshipGerman
Alma mater
Awards
Scientific career
Fieldscell biology, molecular biology
Institutions
Thesis (1991)
Doctoral advisorWerner Franke

Jan-Michael Peters (born 16 August 1962 in Schleswig-Holstein, Germany) is a cell- and molecular biologist. Since 2013, he is Scientific Director of the Research Institute of Molecular Pathology (IMP) in Vienna.

Early life and education

Jan-Michael Peters grew up in Schleswig-Holstein and referred to an interest in biology that goes back to his childhood.[1]

Peters started studying at the University of Kiel in 1982, where he received his pre-diploma in Biology. In 1988, he completed his diploma studies at the University of Heidelberg, where he also obtained his PhD in cell biology in 1991. Working with Werner Franke during his PhD studies, Peters discovered p97-ATPase and first characterized the 26S proteasome.[2]

Career and research

Between 1992 and 1993, Peters continued working with Werner W. Franke as a postdoctoral fellow at the German Cancer Research Center DKFZ in Heidelberg, where he worked on the first purification and electron microscopy of 26S proteasome.[2]

In 1994, Peters joined the lab of Marc W. Kirschner at Harvard Medical School in Boston as a postdoctoral fellow. There, he discovered the anaphase promoting complex/cyclosome (APC/C) and other enzymes required for chromosome segregation.

In 1996, Peters moved to Vienna to become Junior Group Leader at the Research Institute of Molecular Pathology (IMP), and was promoted to Senior Scientist in 2002. In 2011, he became the institute's Scientific Deputy Director and in 2013 Scientific Director, succeeding Barry Dickson.

Peters’ research group studies the molecular mechanisms of chromosome organization, chromosome segregation and cell division in a variety of model organisms.

Peters characterized the regulation and operating principle of a number of proteins that are responsible for the correct chromosome segregation during mitosis. Using the enzyme Polo-like Kinase 1 (Pik1), Peters characterized a cell division enzyme that has shown to be a promising target for chemotherapy against certain cancers.[3][4][5]

Peters was the coordinator of the European Science Foundation network grant EuroDYNA (2005-2008) that is fostering interaction among various collaborative research projects. He contributed to this program when he discovered the relationship between two proteins, cohesin and CTCF,[6] in regulating the expression and transcription of genes.[7][8]

Between 2004 and 2009, Peters also coordinated the EU funded research project MitoCheck, aimed at the identification of genes that play a key role in the process of mitosis. Between 2010 and 2015, he headed the follow-up project MitoSys, through which biologists, mathematicians, biochemists and biophysicists collaborated to reveal how genes and proteins orchestrate mitosis in human cells. This project was accompanied by an art project seeking to link science and society.[9][10][11][12]

Awards and honours

  • 2016 European Research Council (ERC) Advanced Grant
  • 2014 Full Member of the Austrian Academy of Sciences (ÖAW)
  • 2012 Correspondent Member of the Austrian Academy of Sciences (ÖAW)
  • 2011 Wittgenstein Award
  • 2007 Binder Innovation Prize of the German Society for Cell Biology
  • 2005 Boehringer Ingelheim R&D Award
  • 2002 Novartis Research Prize
  • 2002 Elected European Molecular Biology Organisation (EMBO) member
  • 2001 Roche Research Prize for Cell Biology
  • 2001 EMBO Young Investigator Programme
  • 1994 Falcon Prize German Society for Cell Biology
  • 1992 Scientific awards Junior Scientist Award, Society for Promotion of Molecular Biology
  • 1994–1996 EMBO long term postdoctoral fellowship
  • 1992–1993 Postdoctoral fellowship DKFZ
  • 1983–1988 Fellowships Student fellowship German National Scholarship Foundation

References

  1. ↑ "Es kann immer nur einen Entdecker geben". Derstandard.at. Retrieved 21 December 2017.
  2. 1 2 "Jan-Michael Peters receives Wittgenstein Award 2011" (PDF). Imp.ac.at. Retrieved 21 December 2017.
  3. ↑ "Jan-Michael Peters wird neuer wissenschaftlicher Leiter am Wiener IMP". Derstandard.at. Retrieved 21 December 2017.
  4. ↑ Rudolph, D; Impagnatiello, M. A; Blaukopf, C; Sommer, C; Gerlich, D. W; Roth, M; Tontsch-Grunt, U; Wernitznig, A; Savarese, F; Hofmann, M. H; Albrecht, C; Geiselmann, L; Reschke, M; Garin-Chesa, P; Zuber, J; Moll, J; Adolf, G. R; Kraut, N (2015). "Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemia". Journal of Pharmacology and Experimental Therapeutics. 352 (3): 579–89. doi:10.1124/jpet.114.221150. PMID 25576074.
  5. ↑ Petronczki, M; Lénárt, P; Peters, J. M (2008). "Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1". Developmental Cell. 14 (5): 646–59. doi:10.1016/j.devcel.2008.04.014. PMID 18477449.
  6. ↑ Klöckner, Lydia (25 August 2013). "Molekularbiologie: Skelett aus Eiweiß-Würmchen hält Chromosomen zusammen". Zeit.de. Retrieved 21 December 2017.
  7. ↑ "Europäische Kommission : CORDIS : Nachrichten und Veranstaltungen : EuroDYNA leaves healthy genomic research ecosystem as legacy". cordis.europa.eu. Retrieved 21 December 2017.
  8. ↑ "EuroDyna project". Univie.ac.at. Retrieved 21 December 2017.
  9. ↑ Pathology, The Research Institute of Molecular. "Press Release: "Lens on Life" – Artists and Scientists Explore Cell Division". Imp.ac.at. Retrieved 21 December 2017.
  10. ↑ "MitoSys: Systems Biology of Mitosis". Mitosys.org. Retrieved 21 December 2017.
  11. ↑ "Lens On Life – MitoSys – Artakt". Artakt.co.uk. Retrieved 21 December 2017.
  12. ↑ "Exhibitions – MitoSys: Systems Biology of Mitosis". Mitosys.org. Retrieved 21 December 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.